M1 Kliniken AG

XTRA:M12 주식 보고서

시가총액: €337.0m

이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

M1 Kliniken 과거 수익 실적

과거 기준 확인 4/6

M1 Kliniken의 수입은 연평균 -0.9%의 비율로 감소해 온 반면, Healthcare 산업은 수입이 연평균 0.9%의 비율로 감소했습니다. 매출은 연평균 30.8%의 비율로 증가해 왔습니다. M1 Kliniken의 자기자본이익률은 8.1%이고 순이익률은 3.2%입니다.

주요 정보

-0.9%

수익 성장률

-3.5%

EPS 성장률

Healthcare 산업 성장15.7%
매출 성장률30.8%
자기자본 수익률8.1%
순이익3.2%
최근 수익 업데이트31 Dec 2023

최근 과거 실적 업데이트

Additional Considerations Required While Assessing M1 Kliniken's (ETR:M12) Strong Earnings

Jun 06
Additional Considerations Required While Assessing M1 Kliniken's (ETR:M12) Strong Earnings

Recent updates

Additional Considerations Required While Assessing M1 Kliniken's (ETR:M12) Strong Earnings

Jun 06
Additional Considerations Required While Assessing M1 Kliniken's (ETR:M12) Strong Earnings

M1 Kliniken AG (ETR:M12) Looks Just Right With A 53% Price Jump

May 29
M1 Kliniken AG (ETR:M12) Looks Just Right With A 53% Price Jump

M1 Kliniken (ETR:M12) Might Be Having Difficulty Using Its Capital Effectively

May 03
M1 Kliniken (ETR:M12) Might Be Having Difficulty Using Its Capital Effectively

At €14.40, Is It Time To Put M1 Kliniken AG (ETR:M12) On Your Watch List?

Mar 07
At €14.40, Is It Time To Put M1 Kliniken AG (ETR:M12) On Your Watch List?

Why Investors Shouldn't Be Surprised By M1 Kliniken AG's (ETR:M12) 25% Share Price Surge

Feb 18
Why Investors Shouldn't Be Surprised By M1 Kliniken AG's (ETR:M12) 25% Share Price Surge

Is M1 Kliniken AG (ETR:M12) Trading At A 46% Discount?

Feb 17
Is M1 Kliniken AG (ETR:M12) Trading At A 46% Discount?

An Intrinsic Calculation For M1 Kliniken AG (ETR:M12) Suggests It's 27% Undervalued

Sep 01
An Intrinsic Calculation For M1 Kliniken AG (ETR:M12) Suggests It's 27% Undervalued

Should You Think About Buying M1 Kliniken AG (ETR:M12) Now?

Jun 01
Should You Think About Buying M1 Kliniken AG (ETR:M12) Now?

The Returns On Capital At M1 Kliniken (ETR:M12) Don't Inspire Confidence

Mar 25
The Returns On Capital At M1 Kliniken (ETR:M12) Don't Inspire Confidence

Investors Could Be Concerned With M1 Kliniken's (ETR:M12) Returns On Capital

Dec 17
Investors Could Be Concerned With M1 Kliniken's (ETR:M12) Returns On Capital

Is Now The Time To Look At Buying M1 Kliniken AG (ETR:M12)?

Nov 02
Is Now The Time To Look At Buying M1 Kliniken AG (ETR:M12)?

Time To Worry? Analysts Are Downgrading Their M1 Kliniken AG (ETR:M12) Outlook

May 26
Time To Worry? Analysts Are Downgrading Their M1 Kliniken AG (ETR:M12) Outlook

Analysts Have Lowered Expectations For M1 Kliniken AG (ETR:M12) After Its Latest Results

May 25
Analysts Have Lowered Expectations For M1 Kliniken AG (ETR:M12) After Its Latest Results

Here's What's Concerning About M1 Kliniken's (ETR:M12) Returns On Capital

Dec 06
Here's What's Concerning About M1 Kliniken's (ETR:M12) Returns On Capital

There Are Reasons To Feel Uneasy About M1 Kliniken's (ETR:M12) Returns On Capital

May 22
There Are Reasons To Feel Uneasy About M1 Kliniken's (ETR:M12) Returns On Capital

Here's What M1 Kliniken AG's (ETR:M12) Shareholder Ownership Structure Looks Like

Mar 19
Here's What M1 Kliniken AG's (ETR:M12) Shareholder Ownership Structure Looks Like

We're Watching These Trends At M1 Kliniken (ETR:M12)

Feb 21
We're Watching These Trends At M1 Kliniken (ETR:M12)

M1 Kliniken (ETR:M12) Has Gifted Shareholders With A Fantastic 106% Total Return On Their Investment

Feb 03
M1 Kliniken (ETR:M12) Has Gifted Shareholders With A Fantastic 106% Total Return On Their Investment

Are Dividend Investors Getting More Than They Bargained For With M1 Kliniken AG's (ETR:M12) Dividend?

Jan 16
Are Dividend Investors Getting More Than They Bargained For With M1 Kliniken AG's (ETR:M12) Dividend?

M1 Kliniken AG's (ETR:M12) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?

Dec 29
M1 Kliniken AG's (ETR:M12) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?

Here's Why We Don't Think M1 Kliniken's (ETR:M12) Statutory Earnings Reflect Its Underlying Earnings Potential

Dec 14
Here's Why We Don't Think M1 Kliniken's (ETR:M12) Statutory Earnings Reflect Its Underlying Earnings Potential

When Should You Buy M1 Kliniken AG (ETR:M12)?

Nov 28
When Should You Buy M1 Kliniken AG (ETR:M12)?

수익 및 비용 분석

M1 Kliniken 수익 창출 및 지출 방식. 최근 보고된 수익 기준, LTM 기준.


수익 및 매출 내역

XTRA:M12 수익, 비용 및 수입 (EUR Millions )
날짜수익수익G+A 비용R&D 비용
31 Dec 233161020
30 Sep 23307820
30 Jun 23297620
31 Mar 23291520
31 Dec 22285420
30 Sep 22287620
30 Jun 22288720
31 Mar 22302820
31 Dec 21315920
30 Sep 21304920
30 Jun 212931020
31 Mar 21226820
31 Dec 20160720
30 Sep 20118720
30 Jun 2076610
31 Mar 2077810
31 Dec 19771010
30 Sep 1973820
30 Jun 1969720
31 Mar 1967720
31 Dec 1865720
30 Sep 1860620
30 Jun 1854520
31 Mar 1851620
31 Dec 1747620
30 Sep 1743610
30 Jun 1740600
31 Mar 1738500
31 Dec 1636500
30 Sep 1640700
30 Jun 16431000
31 Mar 1639800
31 Dec 1535700
31 Dec 1423500
31 Dec 136000

양질의 수익: M12 은 높은 수익을 보유하고 있습니다.

이익 마진 증가: M12 의 현재 순이익 이익률 (3.2%) 작년보다 높습니다 (1.5%).


잉여현금흐름 대 수익 분석


과거 수익 성장 분석

수익추이: M12 의 수입은 지난 5년 동안 매년 0.9% 씩 감소했습니다.

성장 가속화: 지난 1년간 M12 의 수익 증가율( 138% )은 연간 평균( -0.9% 초과합니다. ).

수익 대 산업: 지난 1년간 M12 수익 증가율( 138% )은 Healthcare 업계 -2.2% 초과했습니다.


자기자본 수익률

높은 ROE: M12 의 자본 수익률( 8.1% )은 낮음으로 간주됩니다.


자산 수익률


고용 자본 수익률


과거 성과가 우수한 기업 찾기